GO:0003219 cardiac right ventricle formation: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003219 describes the initial formation of the right cardiac ventricle from unspecified parts, a key step in cardiac morphogenesis.
• The right ventricle (RV) is a distinct chamber with unique anatomy and function, and its failure is a major cause of morbidity in congenital and acquired heart disease.
• Transcription factors such as Hey2, Tbx2, and Mycn are critical for right ventricle development, as shown by perturbation studies in model organisms.
• Disruption of right ventricle formation leads to congenital heart defects and contributes to systemic right ventricle dysfunction in conditions like transposition of the great arteries.
• Research on right ventricle formation uses animal models, stem cell differentiation, and advanced imaging to uncover molecular mechanisms.
• Therapeutic strategies targeting the right ventricle, including stem cell therapy and RAAS blockade, are under investigation for right heart failure.
Description
The right ventricle (RV) is a crucial cardiac chamber responsible for pumping deoxygenated blood to the lungs. Its formation during embryogenesis, defined by the Gene Ontology term GO:0003219 (cardiac right ventricle formation), encompasses the initial developmental processes that specify and shape this chamber from unspecified progenitor cells. Understanding this process is fundamental to developmental biology and congenital heart disease research, as defects in right ventricle formation can lead to severe cardiac malformations. Recent studies have begun to elucidate the transcriptional networks and signaling pathways that govern right ventricle morphogenesis, highlighting the roles of transcription factors such as Hey2, Tbx2, and Mycn. Moreover, the right ventricle's unique anatomy and physiology make it a distinct subject of study, with clinical implications for heart failure and pulmonary hypertension. This article synthesizes current knowledge on the molecular and cellular mechanisms of right ventricle formation, the genes involved, and the research methodologies used to investigate this process, providing a comprehensive resource for researchers and clinicians.
cardiac right ventricle formation At A Glance
| GO ID | GO:0003219 |
|---|---|
| GO term | cardiac right ventricle formation |
| Ontology | biological_process |
| Synonym | None |
| Definition | The developmental process pertaining to the initial formation of a right cardiac ventricle from unspecified parts. |
| Major function | Establishment of the right ventricle during heart development |
| Related processes | Cardiac chamber morphogenesis, heart looping, trabeculation |
| Key regulators | Hey2, Tbx2, Mycn, Nkx2-5, Hand1, Hand2 |
What Is GO:0003219?
GO:0003219, cardiac right ventricle formation, is defined as the developmental process pertaining to the initial formation of a right cardiac ventricle from unspecified parts. This term captures the early events that establish the right ventricle as a distinct chamber, including the specification of progenitor cells, the formation of the primitive heart tube, and the subsequent morphogenetic movements that shape the right ventricle. It is a biological process that is essential for the establishment of a functional four-chambered heart.
Why Is cardiac right ventricle formation Important in Cell Biology?
Cardiac right ventricle formation is critically important because the right ventricle is essential for pulmonary circulation, and its malformation leads to congenital heart defects such as hypoplastic right heart syndrome and double outlet right ventricle. Moreover, right ventricular dysfunction is a major determinant of morbidity and mortality in acquired heart diseases, including pulmonary hypertension and heart failure. Understanding the molecular mechanisms of right ventricle formation can inform regenerative strategies and therapeutic interventions for right heart failure.
• Right ventricle formation is a key step in establishing a functional four-chambered heart.
• Defects in right ventricle development cause congenital heart diseases, including hypoplastic right heart and Ebstein's anomaly.
• The right ventricle has distinct embryological origins and molecular signatures compared to the left ventricle.
• Right ventricular dysfunction is a strong predictor of mortality in heart failure and pulmonary hypertension.
• Studying right ventricle formation aids in understanding cardiac regeneration and stem cell therapies.
• Animal models with perturbations in right ventricle development provide insights into human disease mechanisms.
• The right ventricle's response to pressure overload involves unique hypertrophic signaling pathways.
• Therapeutic targeting of the right ventricle, such as RAAS blockade, is an active area of clinical research.
• Exercise-induced remodeling of the right ventricle highlights its plasticity and adaptation.
• Non-invasive imaging of the right ventricle is crucial for diagnosis and monitoring of right heart diseases.
What Happens During cardiac right ventricle formation?
Specification of Cardiac Progenitors
In simple terms: Early embryonic cells are instructed to become heart cells that will form the right ventricle.
During early embryogenesis, cardiac progenitor cells in the anterior lateral plate mesoderm are specified toward a ventricular fate. This specification involves the activation of a core cardiac transcriptional network, including Nkx2-5, Gata4, and Tbx5, which pattern the heart field. The right ventricle progenitor pool is located in the anterior heart field and is marked by the expression of Hand1 and Hand2. Signaling pathways such as FGF, BMP, and Wnt modulate this specification, ensuring proper allocation of cells to the right ventricle.
Formation of the Primitive Heart Tube
In simple terms: The specified heart cells organize into a simple tube that will later loop and form chambers.
The specified cardiac progenitors migrate and fuse to form the linear heart tube, which consists of an inner endocardial layer and an outer myocardial layer. The heart tube is initially patterned along the anterior-posterior axis, with the future right ventricle located at the anterior pole. This patterning is regulated by gradients of retinoic acid and other morphogens. The heart tube then undergoes rightward looping, a critical step that positions the future right ventricle to the right side of the embryo.
Chamber Specification and Ballooning
In simple terms: The tube balloons out to form distinct chambers, including the right ventricle.
After looping, the heart tube segments into regions that will become the atria, left ventricle, and right ventricle. The right ventricle is specified by a combination of transcription factors, notably Hey2, which represses left ventricular identity and promotes right ventricular gene expression. Hey2 regulates the Tbx2-Mycn pathway, which is essential for right ventricle development. The ballooning morphogenesis involves localized proliferation and differentiation of myocardial cells, leading to the expansion of the right ventricular chamber.
Trabeculation and Myocardial Maturation
In simple terms: The inner lining of the right ventricle forms ridges that increase muscle mass and function.
As the right ventricle expands, the myocardium undergoes trabeculation, a process where myocardial cells form finger-like projections that increase surface area for nutrient exchange and contribute to contractile function. This process is regulated by Notch signaling and neuregulin-1. Defects in trabeculation can lead to cardiomyopathy. The right ventricular myocardium then matures, acquiring its characteristic gene expression profile and physiological properties.
Separation from the Left Ventricle
In simple terms: A wall forms to separate the right and left ventricles.
The interventricular septum forms to separate the right and left ventricles, a process that involves the fusion of the muscular septum with the membranous septum. This septation is crucial for maintaining separate pulmonary and systemic circulations. The development of the right ventricle is closely coordinated with septation, and defects in this process lead to ventricular septal defects. Transcription factors such as Tbx5 and Nkx2-5 are involved in septation.
Key Genes Involved in GO:0003219 cardiac right ventricle formation
The following genes have been implicated in cardiac right ventricle formation based on experimental evidence from model organisms and human genetics.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Hey2 | Transcription factor that promotes right ventricular identity and regulates Tbx2-Mycn pathway | Knockout leads to right ventricle hypoplasia; key regulator of chamber specification |
| Tbx2 | Represses chamber-specific genes; involved in right ventricle development | Downstream of Hey2; modulates myocardial proliferation |
| Mycn | Transcription factor promoting cell proliferation; essential for right ventricle growth | Regulated by Hey2-Tbx2 axis; knockout causes right ventricle hypoplasia |
| Nkx2-5 | Master cardiac transcription factor; patterns the heart tube | Mutations cause congenital heart defects including right ventricle anomalies |
| Hand1 | Transcription factor in anterior heart field; specifies right ventricle progenitors | Knockout results in right ventricle defects |
| Hand2 | Transcription factor in right ventricle myocardium; regulates proliferation | Essential for right ventricle formation; interacts with Hey2 |
| Gata4 | Zinc finger transcription factor; regulates cardiac gene expression | Mutations associated with septal defects affecting right ventricle |
| Tbx5 | T-box transcription factor; involved in heart looping and septation | Mutations cause Holt-Oram syndrome with right ventricle defects |
| Mef2c | MADS-box transcription factor; regulates myocardial differentiation | Required for right ventricle development; downstream of Nkx2-5 |
| Isl1 | LIM-homeodomain transcription factor; marks cardiac progenitors | Lineage tracing shows contribution to right ventricle |
| Srf | Serum response factor; regulates cardiac gene expression | Conditional knockout affects right ventricle formation |
| Pitx2 | Paired-like homeodomain transcription factor; left-right asymmetry | Mutations cause right atrial isomerism and right ventricle defects |
| Notch1 | Transmembrane receptor; regulates trabeculation | Involved in right ventricle trabeculation; mutations linked to congenital heart disease |
| Nrg1 | Neuregulin-1; ligand for ErbB receptors; promotes trabeculation | Knockout results in defective right ventricle trabeculation |
| Bmp10 | Bone morphogenetic protein; regulates myocardial proliferation | Essential for right ventricle growth; mutations cause congenital heart defects |
| Fgf8 | Fibroblast growth factor; involved in heart field specification | Regulates right ventricle progenitor pool |
| Wnt2 | Wingless-type MMTV integration site family member 2; modulates cardiac differentiation | Balances progenitor expansion and differentiation in right ventricle |
| Raldh2 | Retinaldehyde dehydrogenase 2; synthesizes retinoic acid | Regulates anterior-posterior patterning of heart tube including right ventricle |
How Is cardiac right ventricle formation Regulated?
The formation of the right ventricle is regulated by a complex interplay of transcription factors, signaling pathways, and epigenetic modifiers. The Hey2-Tbx2-Mycn axis is a key regulatory module; Hey2 directly represses Tbx2, which in turn modulates Mycn expression to control cardiomyocyte proliferation. Additionally, signaling pathways such as Notch, Neuregulin-1/ErbB, BMP, FGF, and Wnt are critical for various steps of right ventricle development. Retinoic acid signaling, mediated by Raldh2, patterns the heart tube along the anterior-posterior axis, influencing right ventricle specification. Epigenetic regulators, including histone modifiers and chromatin remodelers, also play roles, though specific mechanisms in right ventricle formation are still being elucidated.
cardiac right ventricle formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NKX2-5 | Congenital heart defects, including right ventricle hypoplasia | Knockout mouse, patient-derived iPSCs |
| TBX5 | Holt-Oram syndrome with right ventricle defects | Knockout mouse, zebrafish |
| HEY2 | Right ventricle hypoplasia in animal models | Knockout mouse, CRISPR KO in iPSCs |
| MYCN | Right ventricle hypoplasia; implicated in chamber growth | Conditional knockout mouse |
| HAND1 | Right ventricle defects in knockout models | Knockout mouse |
Congenital Heart Defects
Disruptions in cardiac right ventricle formation lead to a spectrum of congenital heart defects, including hypoplastic right heart syndrome, double outlet right ventricle, and ventricular septal defects. Mutations in key transcription factors such as NKX2-5, TBX5, and GATA4 have been associated with these conditions. Understanding the genetic basis of right ventricle malformations is essential for diagnosis and potential therapeutic intervention.
Right Ventricular Dysfunction in Acquired Heart Disease
The right ventricle is vulnerable to dysfunction in acquired heart diseases such as pulmonary hypertension, myocardial infarction, and heart failure. Right ventricular failure is a strong predictor of mortality in these conditions. The right ventricle's unique response to pressure overload involves hypertrophic signaling pathways that differ from the left ventricle, including the renin-angiotensin-aldosterone system. Research into right ventricle formation may inform strategies to promote regeneration or protect the right ventricle in acquired disease.
Systemic Right Ventricle in Transposition of the Great Arteries
In patients with transposition of the great arteries who have undergone atrial switch repair, the right ventricle supports the systemic circulation. This systemic right ventricle often fails over time, leading to heart failure. Understanding the developmental biology of the right ventricle may provide insights into why it is less suited for systemic workload and how to therapeutically target its dysfunction. Stem cell therapy is being explored as a potential treatment for systemic right ventricle failure.
From cardiac right ventricle formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate right ventricle specification? | Knockout mouse (conditional), zebrafish morpholino |
| What is the effect of a point mutation in gene Y on right ventricle formation? | Knock-in mouse, CRISPR point mutation in iPSCs |
| Can overexpression of gene Z rescue right ventricle defects? | Transgenic overexpression mouse, lentiviral overexpression in iPSCs |
| Where is protein X localized during right ventricle development? | Tagged knock-in mouse (e.g., GFP), immunofluorescence |
| What are the transcriptomic changes in right ventricle progenitors? | RNA-seq of sorted progenitors from knockout/overexpression models |
| How does gene W affect right ventricle function in adult heart? | Inducible knockout mouse, AAV-mediated gene editing |
How to Study the cardiac right ventricle formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identifying right ventricle-specific transcriptional programs |
| Single-cell RNA-seq | Cell-type-specific expression | Dissecting progenitor heterogeneity during right ventricle formation |
| ChIP-seq | Transcription factor binding sites | Mapping Hey2, Tbx2, Mycn targets in right ventricle |
| Lineage tracing | Cell fate and contribution | Tracking progenitor cells that form the right ventricle |
| Echocardiography | Right ventricle structure and function | Assessing right ventricle in mouse models and patients |
| Cardiac MRI | Right ventricle volume and function | Clinical evaluation of right ventricle in congenital heart disease |
| Immunofluorescence | Protein localization | Visualizing sarcomeric and transcription factor proteins in right ventricle |
| CRISPR screening | Gene function at scale | Identifying novel regulators of right ventricle formation |
Genetic Lineage Tracing
Lineage tracing using Cre-loxP systems in mice allows researchers to follow the fate of cardiac progenitor cells that contribute to the right ventricle. For example, Isl1-Cre and Nkx2-5-Cre lines have been used to map the contribution of specific progenitor pools to the right ventricle. This method provides spatial and temporal resolution of cell fate decisions during right ventricle formation.
Transcriptomic Profiling
RNA sequencing (RNA-seq) of microdissected right ventricle tissue or sorted progenitor cells at different developmental stages reveals gene expression dynamics. Comparative transcriptomics between right and left ventricles has identified unique molecular signatures, such as the enrichment of Hey2 and Tbx2 in the right ventricle. Single-cell RNA-seq further resolves cellular heterogeneity during right ventricle development.
Imaging and Morphometrics
Advanced imaging techniques, including optical coherence tomography, confocal microscopy, and micro-CT, enable three-dimensional visualization of right ventricle morphogenesis in model organisms. These methods quantify chamber volume, trabecular architecture, and myocardial wall thickness. In humans, cardiac MRI and echocardiography assess right ventricle anatomy and function in patients with congenital heart disease.
Functional Assays
Functional assays such as echocardiography in mice, pressure-volume loop analysis, and exercise testing evaluate right ventricle performance. In vitro, cardiomyocyte contractility and calcium handling can be measured in cells derived from right ventricle progenitors. These assays link molecular changes to physiological outcomes.
How CRISPR Can Be Used to Study GO:0003219 cardiac right ventricle formation
Knockout
CRISPR-Cas9 knockout of candidate genes in model organisms or human induced pluripotent stem cells (iPSCs) can reveal their requirement for right ventricle formation. For example, knockout of HEY2 in iPSCs followed by directed differentiation into cardiomyocytes can assess defects in right ventricle-like cells. Knockout mice for Hey2 exhibit right ventricle hypoplasia, validating its essential role.
Point Mutation
Introducing precise point mutations via CRISPR base editing or homology-directed repair allows modeling of human variants associated with congenital heart defects. For instance, a point mutation in NKX2-5 identified in patients can be introduced into iPSCs to study its impact on right ventricle differentiation. This approach provides insights into genotype-phenotype relationships.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags into endogenous loci enables visualization and purification of right ventricle progenitor cells. Tagged knock-in of HEY2 allows tracking of its expression dynamics during differentiation. Knock-in of disease-associated mutations also models human disease in animal models.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of candidate genes can test sufficiency for right ventricle formation. Overexpression of MYCN in cardiac progenitors may enhance right ventricle growth. Conversely, overexpression of a repressor like Tbx2 might inhibit chamber specification. These experiments complement loss-of-function studies.
How EDITGENE Supports cardiac right ventricle formation Research
Researchers studying cardiac right ventricle formation-related genes often need to determine whether a candidate gene is causally involved in the developmental process or contributes to disease. EDITGENE provides a comprehensive suite of CRISPR-based services to facilitate these investigations, from gene knockout to precise point mutations and overexpression, enabling robust functional validation in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for cardiac right ventricle formation research.
Frequently Asked Questions About cardiac right ventricle formation
What is GO:0003219?
GO:0003219 is the Gene Ontology term for cardiac right ventricle formation, defined as the developmental process pertaining to the initial formation of a right cardiac ventricle from unspecified parts.
What genes are involved in cardiac right ventricle formation?
Key genes include HEY2, TBX2, MYCN, NKX2-5, HAND1, HAND2, GATA4, TBX5, and others that regulate cardiac progenitor specification, chamber morphogenesis, and trabeculation.
Why is right ventricle formation important?
Proper right ventricle formation is essential for pulmonary circulation; defects cause congenital heart defects and contribute to right heart failure in acquired diseases.
What diseases are associated with abnormal right ventricle formation?
Diseases include hypoplastic right heart syndrome, double outlet right ventricle, ventricular septal defects, and systemic right ventricle dysfunction in transposition of the great arteries.
How is right ventricle formation studied?
Researchers use animal models (mouse, zebrafish), human iPSCs, lineage tracing, RNA-seq, ChIP-seq, and imaging techniques to study right ventricle development.
What is the role of Hey2 in right ventricle formation?
Hey2 is a transcription factor that promotes right ventricular identity by regulating the Tbx2-Mycn pathway; its knockout leads to right ventricle hypoplasia.
Can CRISPR be used to study right ventricle formation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression in iPSCs or animal models enable functional studies of genes involved in right ventricle development.
What are the research methods for right ventricle formation?
Methods include genetic lineage tracing, transcriptomics, chromatin immunoprecipitation, imaging, and functional assays like echocardiography.
What is the difference between right and left ventricle formation?
The right ventricle has distinct embryological origins and molecular signatures, such as Hey2 expression, compared to the left ventricle, which is marked by Irx4 and other factors.
How does right ventricle dysfunction affect heart failure?
Right ventricular dysfunction is a strong predictor of mortality in heart failure and pulmonary hypertension, often determining clinical outcomes.
Conclusion
Cardiac right ventricle formation (GO:0003219) is a fundamental developmental process that establishes a critical chamber of the heart. Research over the past decades has identified key transcription factors and signaling pathways, such as the Hey2-Tbx2-Mycn axis, that orchestrate this process. Defects in right ventricle formation lead to congenital heart defects, and right ventricular dysfunction is a major contributor to morbidity in acquired heart diseases. Continued investigation using advanced genetic, imaging, and stem cell technologies promises to unravel the complexities of right ventricle development and inform therapeutic strategies for right heart failure. EDITGENE's CRISPR services can support these efforts by providing precise cell models for functional validation.
References
- 1. Sanz J et al.. 2019. Anatomy, Function, and Dysfunction of the Right Ventricle: JACC State-of-the-Art Review.. J Am Coll Cardiol 73(12):1463-1482 PMID: 30922478
- 2. Gargiulo P et al.. 2015. Nuclear assessment of right ventricle.. Echocardiography 32 Suppl 1:S69-74 PMID: 25238036
- 3. Oláh A et al.. 2025. Long-term exercise training is associated with unique cardiac troponin I phosphorylation pattern and benign myocardial hypertrophy in the right ventricle in an experimental model of exercise-induced myocardial remodelling.. J Mol Cell Cardiol 207:81-91 PMID: 40840834
- 4. de Man FS et al.. 2017. A focus on the greatness of the lesser circulation: spotlight issue on the right ventricle.. Cardiovasc Res 113(12):1421-1422 PMID: 28957539
- 5. Si MS et al.. 2017. Stem cell therapy for the systemic right ventricle.. Expert Rev Cardiovasc Ther 15(11):813-823 PMID: 28914109
- 6. Seya D et al.. 2021. A role of Hey2 transcription factor for right ventricle development through regulation of Tbx2-Mycn pathway during cardiac morphogenesis.. Dev Growth Differ 63(1):82-92 PMID: 33410138
- 7. Brida M et al.. 2019. Renin-angiotensin-aldosterone system blockade in systemic right ventricle.. Int J Cardiol 279:62-63 PMID: 30638983
- 8. Dhalla NS et al.. 2024. Behavior of Hypertrophied Right Ventricle during the Development of Left Ventricular Failure Due to Myocardial Infarction.. Int J Mol Sci 25(5) PMID: 38473855
